SJ Medical
SJ Medical
Smartphone-Compatible Ultrasound Probe C10CS
LED Therapy Carotid Artery Care Device
Universal C10MS Pro Handheld Probe
Cervical Carotid Artery Anatomy Model
Mobile Cart 2D Vascular Doppler Scanner
Rechargeable Handheld Imaging Probe
Precision Nitinol Thrombectomy Stent
Disposable Peripheral Intervention Guidewire
The global medical community is witnessing a paradigm shift in the treatment of carotid artery disease. As a leading Carotid Artery Stenting Factory, we observe that Carotid Artery Stenting (CAS) has evolved from an alternative to Carotid Endarterectomy (CEA) into a primary treatment modality for high-risk surgical patients. The global market is driven by an aging population, rising incidences of stroke, and the demand for minimally invasive procedures that offer faster recovery times and reduced hospital stays.
Currently, the industrial status of CAS is defined by a rigorous push toward neuro-interventional precision. Manufacturers and exporters across the globe are focusing on the synergy between stent design, delivery systems, and embolic protection devices (EPD). Our role as a prominent Chinese exporter is to bridge the gap between high-end technological innovation and cost-effective accessibility for healthcare systems in Europe, Asia, and the Americas.
The shift towards super-elastic Nitinol materials allows for stents with superior kink resistance and "shape memory," essential for the dynamic environment of the carotid artery.
Integration of AI with intravascular ultrasound (IVUS) and Doppler scanners is revolutionizing how surgeons visualize plaque morphology before stent deployment.
Modern CAS kits now integrate advanced distal filter devices to capture debris, significantly lowering the risk of periprocedural stroke.
Moreover, the trend toward Dual-Layer Stent designs—combining a structural outer layer with a fine mesh inner layer—is gaining traction. This "micromesh" technology is designed to prevent plaque protrusion through the stent struts, a common cause of late-term complications. As a dedicated factory, we are investing heavily in laser-cutting precision and surface treatment technologies to stay ahead of these international standards.
Hangzhou SJ Medical Co., Ltd. was established in 2015 and is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide.
Over the years, SJ Medical has developed a comprehensive product portfolio covering key areas of vascular intervention. Its offerings span from various types of balloon catheters for coronary and peripheral applications to supporting access and diagnostic devices, as well as advanced stent systems. Through continuous innovation and strong R&D capabilities, the company has obtained multiple patents and international certifications, laying a solid foundation for sustainable growth in both domestic and global markets.
SJ Medical operates a modern manufacturing facility with a total area of approximately 5,000 square meters. The factory is built in accordance with GMP standards and features a high-standard cleanroom environment, including a million-class clean workshop with localized hundred-class areas for critical processes.
The company is supported by a highly experienced technical team, many of whom have been engaged in the medical device industry for decades. Under the leadership of senior engineers, SJ Medical maintains strict quality control and continuously improves its manufacturing processes to ensure product reliability and consistency. Our factory uses precision balloon forming equipment and laser welding technologies to maintain a leading edge in the competitive interventional market.
Our proximity to high-tech industrial hubs in Hangzhou allows us to source medical-grade raw materials and components with unmatched speed and efficiency.
We offer premium, CE-certified medical devices at competitive price points by optimizing large-scale production without compromising on quality or safety.
With years of experience as exporters to Europe, Asia, and the Middle East, we handle complex logistics and regulatory documentation with ease.
For global procurement officers, the decision to source from a Chinese factory like SJ Medical is driven by the balance of "Advanced Technology" and "Scalable Output." Global buyers today are not just looking for a product; they are looking for a long-term R&D partner. Our capability to provide OEM/ODM services for specialized catheter systems and stents makes us a vital link in the global medical supply chain.
Our Carotid Artery Stenting and diagnostic tools are designed for diverse clinical environments:
SJ Medical strictly adheres to international quality standards and regulatory requirements. The company has obtained CE certification, ISO 13485 quality management system certification, and CFDA approval, along with free sale certificates, demonstrating its strong commitment to product quality and compliance.
We have established long-term partnerships with clients across Europe, Asia, the Middle East, and Africa. Our products are currently distributed in countries such as Finland, Italy, Spain, France, the Netherlands, India, Indonesia, Turkey, and Egypt. We continue to expand our international footprint daily.
As a global Carotid Artery Stenting Factory and Exporter, SJ Medical is more than just a manufacturer. We are an innovation partner committed to E-E-A-T principles. Our deep expertise in Nitinol processing, combined with our experience in the global medical device market, ensures that every stent and catheter we produce meets the highest standards of reliability. Whether you are a distributor looking for high-quality interventional devices or a hospital seeking advanced surgical tools, SJ Medical provides the technology and support to save lives and improve patient outcomes. Contact our technical team today to discuss your procurement requirements and join our growing network of global healthcare partners.
